These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7617303)

  • 1. Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein.
    Karhunen T; Tilgmann C; Ulmanen I; Panula P
    Neurosci Lett; 1995 Feb; 187(1):57-60. PubMed ID: 7617303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment.
    Delprato A; Xiao E; Manoj D
    Behav Brain Funct; 2022 May; 18(1):7. PubMed ID: 35590332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sansoninto attenuates aggressive behavior and increases levels of homovanillic acid, a dopamine metabolite, in social isolation-reared mice.
    Watanabe T; Iba H; Moriyama H; Kubota K; Katsurabayashi S; Iwasaki K
    J Tradit Complement Med; 2022 May; 12(3):243-249. PubMed ID: 35493307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology of Astroglia.
    Verkhratsky A; Nedergaard M
    Physiol Rev; 2018 Jan; 98(1):239-389. PubMed ID: 29351512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice.
    Gasser PJ; Hurley MM; Chan J; Pickel VM
    Brain Struct Funct; 2017 May; 222(4):1913-1928. PubMed ID: 27659446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.
    Malmlöf T; Feltmann K; Konradsson-Geuken Å; Schneider F; Alken RG; Svensson TH; Schilström B
    J Neural Transm (Vienna); 2015 Feb; 122(2):259-72. PubMed ID: 24906468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum.
    Simpson EH; Morud J; Winiger V; Biezonski D; Zhu JP; Bach ME; Malleret G; Polan HJ; Ng-Evans S; Phillips PE; Kellendonk C; Kandel ER
    Learn Mem; 2014 Mar; 21(4):205-14. PubMed ID: 24639487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain.
    Schendzielorz N; Oinas JP; Myöhänen TT; Reenilä I; Raasmaja A; Männistö PT
    PLoS One; 2013; 8(4):e61392. PubMed ID: 23613844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.
    Marom L; Ulitsky I; Cabilly Y; Shamir R; Elroy-Stein O
    PLoS One; 2011; 6(10):e26992. PubMed ID: 22073122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development.
    Chen J; Song J; Yuan P; Tian Q; Ji Y; Ren-Patterson R; Liu G; Sei Y; Weinberger DR
    J Biol Chem; 2011 Oct; 286(40):34752-60. PubMed ID: 21846718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.
    Lam HA; Wu N; Cely I; Kelly RL; Hean S; Richter F; Magen I; Cepeda C; Ackerson LC; Walwyn W; Masliah E; Chesselet MF; Levine MS; Maidment NT
    J Neurosci Res; 2011 Jul; 89(7):1091-102. PubMed ID: 21488084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-Bound Catechol-O-Methyl Transferase in Cortical Neurons and Glial Cells is Intracellularly Oriented.
    Schott BH; Frischknecht R; Debska-Vielhaber G; John N; Behnisch G; Düzel E; Gundelfinger ED; Seidenbecher CI
    Front Psychiatry; 2010; 1():142. PubMed ID: 21423451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice.
    Tammimäki A; Käenmäki M; Kambur O; Kulesskaya N; Keisala T; Karvonen E; García-Horsman JA; Rauvala H; Männistö PT
    Psychopharmacology (Berl); 2010 Sep; 211(4):389-401. PubMed ID: 20617305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets.
    Zeng BY; Balfour RH; Jackson MJ; Rose S; Jenner P
    J Neural Transm (Vienna); 2010 Jan; 117(1):45-51. PubMed ID: 19771390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase.
    Tchivileva IE; Nackley AG; Qian L; Wentworth S; Conrad M; Diatchenko LB
    Mol Pain; 2009 Mar; 5():13. PubMed ID: 19291302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase and its inhibitors in Parkinson's disease.
    Bonifácio MJ; Palma PN; Almeida L; Soares-da-Silva P
    CNS Drug Rev; 2007; 13(3):352-79. PubMed ID: 17894650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum.
    Yavich L; Forsberg MM; Karayiorgou M; Gogos JA; Männistö PT
    J Neurosci; 2007 Sep; 27(38):10196-209. PubMed ID: 17881525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
    Apud JA; Weinberger DR
    CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated clorgyline treatment inhibits methamphetamine-induced behavioral sensitization in mice.
    Kitanaka N; Kitanaka J; Takemura M
    Neurochem Res; 2005 Apr; 30(4):445-51. PubMed ID: 16076014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
    Gerlach M; Xiao AY; Kuhn W; Lehnfeld R; Waldmeier P; Sontag KH; Riederer P
    J Neural Transm (Vienna); 2001; 108(2):189-204. PubMed ID: 11314772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.